Stem Cell Therapy and Nanotechnology in Diabetes

A successful bone marrow or stem cell transplant may help slow or halt the progression of certain metabolic syndromes including type 1 diabetes, but early diagnosis is critical to prevent irreversible disease progression. Pancreatic islet allotransplantation is a procedure in which islets from the donor pancreas are transferred into another person to treat type 1 diabetes and have been a promising cellular-based therapy. The recent advances in nanomedicine include smart drugs which only activate when needed, nanoformulations for efficient drug delivery, engineered microbes which produce human hormones, and even nanorobots, which would move autonomously around the body acting as a boost, for our immune system, red blood cells, or many other biological systems.

  • Islet Cell Transplantation
  • Embryonic Stem Cells
  • Mesenchymal Stem Cell Therapy

Related Conference of Stem Cell Therapy and Nanotechnology in Diabetes

March 25-26, 2024

5th Annual Conference on Diabetes

London, UK
July 11-12, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Stem Cell Therapy and Nanotechnology in Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in